Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis
Authors
Keywords
-
Journal
Therapeutic Advances in Neurological Disorders
Volume 9, Issue 6, Pages 454-461
Publisher
SAGE Publications
Online
2016-08-05
DOI
10.1177/1756285616661929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry
- (2015) Athena Hadjixenofontos et al. NEUROEPIDEMIOLOGY
- PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
- (2015) Thorsten Rosenkranz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk
- (2015) Bhupendra O. Khatri et al. Multiple Sclerosis and Related Disorders
- Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses
- (2014) Angel R. Chinea Martinez et al. ADVANCES IN THERAPY
- Dimethyl fumarate associated lymphopenia in clinical practice
- (2014) Erin E Longbrake et al. Multiple Sclerosis Journal
- Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis
- (2014) Jagannadha Avasarala JAMA Neurology
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study
- (2013) Michael Hutchinson et al. JOURNAL OF NEUROLOGY
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the DEFINE study
- (2013) Amit Bar-Or et al. JOURNAL OF NEUROLOGY
- Incidence of multiple sclerosis in multiple racial and ethnic groups
- (2013) A. Langer-Gould et al. NEUROLOGY
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis
- (2011) Bruce A. C. Cree et al. ARCHIVES OF NEUROLOGY
- Multiple sclerosis in Hispanics: a study of clinical disease expression
- (2011) L Amezcua et al. Multiple Sclerosis Journal
- Rapid disease course in African Americans with multiple sclerosis
- (2010) I. Kister et al. NEUROLOGY
- Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA
- (2009) Bruce A. C. Cree et al. ARCHIVES OF NEUROLOGY
- Racial and Ethnic Disparities in the VA Health Care System: A Systematic Review
- (2008) Somnath Saha et al. JOURNAL OF GENERAL INTERNAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started